G17DT Immunogen

BIOLOGICAL2 trials

Sponsors

Jonsson Comprehensive Cancer Center, Cancer Advances Inc.

Conditions

Esophageal CancerGastric CancerPancreatic Cancer

Phase 3

Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma

CompletedNCT00044031

Cancer Advances Inc.Pancreatic Cancer

Start: 2001-02-28End: 2007-10-31Updated: 2014-04-17

Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer

CompletedNCT00020787

Jonsson Comprehensive Cancer CenterEsophageal Cancer, Gastric Cancer

Start: 2001-07-31End: 2002-12-31Updated: 2020-08-03